CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch

Today's Daily Dose brings you news about the third-quarter preliminary revenue results of CareDx and Ocular Therapeutix; Lilly pursuing emergency use authorization for LY-CoV555 in high-risk COVID-19 patients, and dual government support for TLC in developing a COVID-19 therapy.

from RTT - Biotech https://ift.tt/2GJyfuP
via IFTTT